This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Nov;184(5):1952.

doi: 10.1016/j.juro.2010.06.165. Epub 2010 Sep 17.

Editorial comment

Virginie Vlaeminck-Guillem

PMID: 20850156
DOI: 10.1016/j.juro.2010.06.165

Editorial

Editorial comment

Virginie Vlaeminck-Guillem. J Urol. 2010 Nov.

. 2010 Nov;184(5):1952.

doi: 10.1016/j.juro.2010.06.165. Epub 2010 Sep 17.

Author

Virginie Vlaeminck-Guillem

PMID: 20850156
DOI: 10.1016/j.juro.2010.06.165

No abstract available

PubMed Disclaimer

Comment on

PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial.
Aubin SM, Reid J, Sarno MJ, Blase A, Aussie J, Rittenhouse H, Rittmaster R, Andriole GL, Groskopf J. Aubin SM, et al. J Urol. 2010 Nov;184(5):1947-52. doi: 10.1016/j.juro.2010.06.098. Epub 2010 Sep 17. J Urol. 2010. PMID: 20850153

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources